Delivery Order SPE2DB20D3111-SPE2DB25FA8QX
Award Date 7/24/25
Potential Completion Date 7/25/25
Potential Value $5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count package) valued at $5,513.58. This firm fixed-price delivery order, with an ultimate completion date of July 16, 2025, represents a non-competitive award under a larger contract vehicle. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $7,794.93 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count unit). The contract utilizes firm fixed-price pricing with an ultimate completion date of July 29, 2025, and represents a non-competitive, non-set-aside award. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) with a ceiling value of $33,370.13. This firm fixed-price delivery order, which is not set-aside and competitively awarded, is performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Myrbetriq ER 25 mg tablets (90-count units) with a ceiling value of $26,574.02. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order with an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $10,190.42. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award to support federal medical procurement needs. The order is set for ultimate completion by July 17, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $30,440.85. This firm fixed-price delivery order, which is a child contract under a larger vehicle, reflects no set-aside designation and represents a competitively awarded transaction. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $4,216.17. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for completion by August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Myrbetriq ER 25 mg tablets (90-count) with a ceiling value of $1,725.58. This non-competitive delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The firm fixed price delivery order is scheduled for completion by July 31, 2025, with performance...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $42,382.77 on August 27, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). The contract is classified as a firm fixed price delivery order with an ultimate completion date of August 28, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) with a contract ceiling value of $7,553.60. This is a firm fixed-price delivery order with no set-aside designation, utilizing open and competitive procurement procedures. The contract is set to complete by August 1, 2025, and represents a direct fulfillment of pharmaceutical supply needs through AmerisourceBergen's existing...